Department of Medical Cosmetology, Linyi Central Hospital, Linyi, 276400, P. R. China.
Interventional Therapy Department Ward 1, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, P. R. China.
Chem Biodivers. 2021 May;18(5):e2100065. doi: 10.1002/cbdv.202100065. Epub 2021 Apr 16.
This study investigated the protective effects of two polysaccharides (CPA-1 and CPB-2) from Cordyceps cicadae against high fructose/high fat diet (HF/HFD) induced obesity and metabolic disorders in rats. Rats were either fed with normal diet or HF/HFD and treated with CPA-1 and CPB-2 (100 and 300 mg/kg) for 11 weeks. Administration of CPA-1 and CPB-2 significantly and dose dependently reduced body and liver weight, insulin and glucose tolerance, serum insulin and glucose levels. Furthermore, serum and hepatic lipid profiles, liver function enzymes and proinflammatory cytokines (TNF-α, IL-1β and IL-6) were markedly reduced. Additionally, CPA-1 and CPB-2 treatment alleviated hepatic oxidative stress by reducing lipid peroxidation level (MDA) and upregulating glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) and catalase (CAT) activities as well as ameliorated histological alterations through the reduction of hepatic lipid accumulation. These results suggested that the polysaccharides from C. cicadae showed protective effects against HF/HFD induced metabolic disturbances and may be considered as a dietary supplement for treating obesity.
本研究探讨了蝉拟青霉中的两种多糖(CPA-1 和 CPB-2)对高果糖/高脂肪饮食(HF/HFD)诱导的肥胖和大鼠代谢紊乱的保护作用。大鼠分别喂食正常饮食或 HF/HFD,并接受 CPA-1 和 CPB-2(100 和 300mg/kg)治疗 11 周。CPA-1 和 CPB-2 的给药显著且剂量依赖性地降低了体重和肝重、胰岛素和葡萄糖耐量、血清胰岛素和葡萄糖水平。此外,血清和肝脂质谱、肝功能酶和促炎细胞因子(TNF-α、IL-1β 和 IL-6)显著降低。此外,CPA-1 和 CPB-2 通过降低脂质过氧化水平(MDA)和上调谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)和过氧化氢酶(CAT)活性来减轻肝氧化应激,同时通过减少肝脂质积累来改善组织学改变。这些结果表明,蝉拟青霉中的多糖对 HF/HFD 诱导的代谢紊乱具有保护作用,可作为治疗肥胖症的膳食补充剂。